Low-risk prostate cancer and low testosterone: What are the acceptable alternatives?

[1] D'Amico A.V., Whittington R., Malkowicz S.B., Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer, JAMA, 280, pp. 969-974, (1998)

[2] Fowler F.J., McNaughton Collins M., Albertsen P.C., Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer, JAMA, 283, pp. 3217-3222, (2000)

[3] Bill-Axelson A., Holmberg L., Ruutu M., Radical prostatectomy versus watchful waiting in early prostate cancer, N Engl J Med, 352, pp. 1977-1984, (2005)

[4] Albertsen P.C., Hanley J.A., Fine J., 20-year outcomes following conservative management of clinically localized prostate cancer, JAMA, 293, pp. 2095-2101, (2005)

[5] Whitmore W.F., Proceedings: the natural history of prostatic cancer, Cancer, 32, pp. 1104-1112, (1973)

[6] Klotz L., Active surveillance for prostate cancer: for whom?, J Clin Oncol, 23, pp. 8165-8169, (2005)

[7] Carter H.B., Walsh P.C., Landis P., Epstein J.I., Expectant management of nonpalpable prostate cancer with curative intent: preliminary results, J Urol, 167, pp. 1231-1234, (2002)

[8] Warlick C., Trock B.J., Lands P., Delayed versus immediate surgical intervention and prostate cancer outcome, J Natl Cancer Inst, 98, pp. 355-357, (2006)

[9] Walsh P.C., DeWeese T.L., Eisenberger M.A., Clinical practice. Localized prostate cancer, N Engl J Med, 357, pp. 2696-2705, (2007)

[10] Krahn M.D., Bremner K.E., Asaria J., The ten-year rule revisited: accuracy of clinicians’ estimates of life expectancy in patients with localized prostate cancer, Urology, 60, pp. 258-263, (2002)

[1] D'Amico A.V., Whittington R., Malkowicz S.B., Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer, JAMA, 280, pp. 969-974, (1998)

[2] Fowler F.J., McNaughton Collins M., Albertsen P.C., Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer, JAMA, 283, pp. 3217-3222, (2000)

[3] Bill-Axelson A., Holmberg L., Ruutu M., Radical prostatectomy versus watchful waiting in early prostate cancer, N Engl J Med, 352, pp. 1977-1984, (2005)

[4] Albertsen P.C., Hanley J.A., Fine J., 20-year outcomes following conservative management of clinically localized prostate cancer, JAMA, 293, pp. 2095-2101, (2005)

[5] Whitmore W.F., Proceedings: the natural history of prostatic cancer, Cancer, 32, pp. 1104-1112, (1973)

[6] Klotz L., Active surveillance for prostate cancer: for whom?, J Clin Oncol, 23, pp. 8165-8169, (2005)

[7] Carter H.B., Walsh P.C., Landis P., Epstein J.I., Expectant management of nonpalpable prostate cancer with curative intent: preliminary results, J Urol, 167, pp. 1231-1234, (2002)

[8] Warlick C., Trock B.J., Lands P., Delayed versus immediate surgical intervention and prostate cancer outcome, J Natl Cancer Inst, 98, pp. 355-357, (2006)

[9] Walsh P.C., DeWeese T.L., Eisenberger M.A., Clinical practice. Localized prostate cancer, N Engl J Med, 357, pp. 2696-2705, (2007)

[10] Krahn M.D., Bremner K.E., Asaria J., The ten-year rule revisited: accuracy of clinicians’ estimates of life expectancy in patients with localized prostate cancer, Urology, 60, pp. 258-263, (2002)